Rhabdomyosarcoma Drug
Rhabdomyosarcoma Drug market is segmented by Type and by Application. Players, stakeholders, and ... Read More
Global Transthyretin Market Insights and Forecast to 2031
1 Study Coverage
1.1 Transthyretin Product Introduction
1.2 Market by Type
1.2.1 Global Transthyretin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AG-10
1.2.3 ALN-TTRsc02
1.2.4 CRX-1008
1.2.5 EDE-1307
1.2.6 Inotersen Sodium
1.2.7 Others
1.3 Market by Application
1.3.1 Global Transthyretin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Familial Amyloid Neuropathies
1.3.3 Alzheimer's Disease
1.3.4 Cardomyopathy
1.3.5 Neuropathy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transthyretin Sales Estimates and Forecasts 2017-2028
2.2 Global Transthyretin Revenue Estimates and Forecasts 2017-2028
2.3 Global Transthyretin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Transthyretin Sales by Region
2.4.1 Global Transthyretin Sales by Region (2017-2022)
2.4.2 Global Sales Transthyretin by Region (2023-2028)
2.5 Global Transthyretin Revenue by Region
2.5.1 Global Transthyretin Revenue by Region (2017-2022)
2.5.2 Global Transthyretin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Transthyretin Sales by Manufacturers
3.1.1 Global Top Transthyretin Manufacturers by Sales (2017-2022)
3.1.2 Global Transthyretin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Transthyretin in 2021
3.2 Global Transthyretin Revenue by Manufacturers
3.2.1 Global Transthyretin Revenue by Manufacturers (2017-2022)
3.2.2 Global Transthyretin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Transthyretin Revenue in 2021
3.3 Global Transthyretin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Transthyretin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Transthyretin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Transthyretin Sales by Type
4.1.1 Global Transthyretin Historical Sales by Type (2017-2022)
4.1.2 Global Transthyretin Forecasted Sales by Type (2023-2028)
4.1.3 Global Transthyretin Sales Market Share by Type (2017-2028)
4.2 Global Transthyretin Revenue by Type
4.2.1 Global Transthyretin Historical Revenue by Type (2017-2022)
4.2.2 Global Transthyretin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Transthyretin Revenue Market Share by Type (2017-2028)
4.3 Global Transthyretin Price by Type
4.3.1 Global Transthyretin Price by Type (2017-2022)
4.3.2 Global Transthyretin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Transthyretin Sales by Application
5.1.1 Global Transthyretin Historical Sales by Application (2017-2022)
5.1.2 Global Transthyretin Forecasted Sales by Application (2023-2028)
5.1.3 Global Transthyretin Sales Market Share by Application (2017-2028)
5.2 Global Transthyretin Revenue by Application
5.2.1 Global Transthyretin Historical Revenue by Application (2017-2022)
5.2.2 Global Transthyretin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Transthyretin Revenue Market Share by Application (2017-2028)
5.3 Global Transthyretin Price by Application
5.3.1 Global Transthyretin Price by Application (2017-2022)
5.3.2 Global Transthyretin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Transthyretin Market Size by Type
6.1.1 North America Transthyretin Sales by Type (2017-2028)
6.1.2 North America Transthyretin Revenue by Type (2017-2028)
6.2 North America Transthyretin Market Size by Application
6.2.1 North America Transthyretin Sales by Application (2017-2028)
6.2.2 North America Transthyretin Revenue by Application (2017-2028)
6.3 North America Transthyretin Market Size by Country
6.3.1 North America Transthyretin Sales by Country (2017-2028)
6.3.2 North America Transthyretin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Transthyretin Market Size by Type
7.1.1 Europe Transthyretin Sales by Type (2017-2028)
7.1.2 Europe Transthyretin Revenue by Type (2017-2028)
7.2 Europe Transthyretin Market Size by Application
7.2.1 Europe Transthyretin Sales by Application (2017-2028)
7.2.2 Europe Transthyretin Revenue by Application (2017-2028)
7.3 Europe Transthyretin Market Size by Country
7.3.1 Europe Transthyretin Sales by Country (2017-2028)
7.3.2 Europe Transthyretin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Transthyretin Market Size by Type
8.1.1 Asia Pacific Transthyretin Sales by Type (2017-2028)
8.1.2 Asia Pacific Transthyretin Revenue by Type (2017-2028)
8.2 Asia Pacific Transthyretin Market Size by Application
8.2.1 Asia Pacific Transthyretin Sales by Application (2017-2028)
8.2.2 Asia Pacific Transthyretin Revenue by Application (2017-2028)
8.3 Asia Pacific Transthyretin Market Size by Region
8.3.1 Asia Pacific Transthyretin Sales by Region (2017-2028)
8.3.2 Asia Pacific Transthyretin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Transthyretin Market Size by Type
9.1.1 Latin America Transthyretin Sales by Type (2017-2028)
9.1.2 Latin America Transthyretin Revenue by Type (2017-2028)
9.2 Latin America Transthyretin Market Size by Application
9.2.1 Latin America Transthyretin Sales by Application (2017-2028)
9.2.2 Latin America Transthyretin Revenue by Application (2017-2028)
9.3 Latin America Transthyretin Market Size by Country
9.3.1 Latin America Transthyretin Sales by Country (2017-2028)
9.3.2 Latin America Transthyretin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Transthyretin Market Size by Type
10.1.1 Middle East and Africa Transthyretin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Transthyretin Revenue by Type (2017-2028)
10.2 Middle East and Africa Transthyretin Market Size by Application
10.2.1 Middle East and Africa Transthyretin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Transthyretin Revenue by Application (2017-2028)
10.3 Middle East and Africa Transthyretin Market Size by Country
10.3.1 Middle East and Africa Transthyretin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Transthyretin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Alnylam Pharmaceuticals Inc
11.1.1 Alnylam Pharmaceuticals Inc Corporation Information
11.1.2 Alnylam Pharmaceuticals Inc Overview
11.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Alnylam Pharmaceuticals Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alnylam Pharmaceuticals Inc Recent Developments
11.2 Arcturus Therapeutics Inc
11.2.1 Arcturus Therapeutics Inc Corporation Information
11.2.2 Arcturus Therapeutics Inc Overview
11.2.3 Arcturus Therapeutics Inc Transthyretin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Arcturus Therapeutics Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Arcturus Therapeutics Inc Recent Developments
11.3 Ionis Pharmaceuticals Inc
11.3.1 Ionis Pharmaceuticals Inc Corporation Information
11.3.2 Ionis Pharmaceuticals Inc Overview
11.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Ionis Pharmaceuticals Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ionis Pharmaceuticals Inc Recent Developments
11.4 Neurimmune Holding AG
11.4.1 Neurimmune Holding AG Corporation Information
11.4.2 Neurimmune Holding AG Overview
11.4.3 Neurimmune Holding AG Transthyretin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Neurimmune Holding AG Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Neurimmune Holding AG Recent Developments
11.5 Pfizer Inc
11.5.1 Pfizer Inc Corporation Information
11.5.2 Pfizer Inc Overview
11.5.3 Pfizer Inc Transthyretin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Inc Recent Developments
11.6 Prothena Corp Plc
11.6.1 Prothena Corp Plc Corporation Information
11.6.2 Prothena Corp Plc Overview
11.6.3 Prothena Corp Plc Transthyretin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Prothena Corp Plc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Prothena Corp Plc Recent Developments
11.7 Regeneron Pharmaceuticals Inc
11.7.1 Regeneron Pharmaceuticals Inc Corporation Information
11.7.2 Regeneron Pharmaceuticals Inc Overview
11.7.3 Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Regeneron Pharmaceuticals Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Regeneron Pharmaceuticals Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Transthyretin Industry Chain Analysis
12.2 Transthyretin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transthyretin Production Mode & Process
12.4 Transthyretin Sales and Marketing
12.4.1 Transthyretin Sales Channels
12.4.2 Transthyretin Distributors
12.5 Transthyretin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Transthyretin Industry Trends
13.2 Transthyretin Market Drivers
13.3 Transthyretin Market Challenges
13.4 Transthyretin Market Restraints
14 Key Findings in The Global Transthyretin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Transthyretin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of AG-10
Table 3. Major Manufacturers of ALN-TTRsc02
Table 4. Major Manufacturers of CRX-1008
Table 5. Major Manufacturers of EDE-1307
Table 6. Major Manufacturers of Inotersen Sodium
Table 7. Major Manufacturers of Others
Table 8. Global Transthyretin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Transthyretin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Transthyretin Sales by Region (2017-2022) & (K Pcs)
Table 11. Global Transthyretin Sales Market Share by Region (2017-2022)
Table 12. Global Transthyretin Sales by Region (2023-2028) & (K Pcs)
Table 13. Global Transthyretin Sales Market Share by Region (2023-2028)
Table 14. Global Transthyretin Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Transthyretin Revenue Market Share by Region (2017-2022)
Table 16. Global Transthyretin Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Transthyretin Revenue Market Share by Region (2023-2028)
Table 18. Global Transthyretin Sales by Manufacturers (2017-2022) & (K Pcs)
Table 19. Global Transthyretin Sales Share by Manufacturers (2017-2022)
Table 20. Global Transthyretin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Transthyretin Revenue Share by Manufacturers (2017-2022)
Table 22. Transthyretin Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 23. Global Transthyretin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Transthyretin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin as of 2021)
Table 25. Transthyretin Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Transthyretin Product Offered
Table 27. Date of Manufacturers Enter into Transthyretin Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 30. Global Transthyretin Sales by Type (2023-2028) & (K Pcs)
Table 31. Global Transthyretin Sales Share by Type (2017-2022)
Table 32. Global Transthyretin Sales Share by Type (2023-2028)
Table 33. Global Transthyretin Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Transthyretin Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Transthyretin Revenue Share by Type (2017-2022)
Table 36. Global Transthyretin Revenue Share by Type (2023-2028)
Table 37. Transthyretin Price by Type (2017-2022) & (USD/Pcs)
Table 38. Global Transthyretin Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 39. Global Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 40. Global Transthyretin Sales by Application (2023-2028) & (K Pcs)
Table 41. Global Transthyretin Sales Share by Application (2017-2022)
Table 42. Global Transthyretin Sales Share by Application (2023-2028)
Table 43. Global Transthyretin Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Transthyretin Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Transthyretin Revenue Share by Application (2017-2022)
Table 46. Global Transthyretin Revenue Share by Application (2023-2028)
Table 47. Transthyretin Price by Application (2017-2022) & (USD/Pcs)
Table 48. Global Transthyretin Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 49. North America Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 50. North America Transthyretin Sales by Type (2023-2028) & (K Pcs)
Table 51. North America Transthyretin Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Transthyretin Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 54. North America Transthyretin Sales by Application (2023-2028) & (K Pcs)
Table 55. North America Transthyretin Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Transthyretin Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Transthyretin Sales by Country (2017-2022) & (K Pcs)
Table 58. North America Transthyretin Sales by Country (2023-2028) & (K Pcs)
Table 59. North America Transthyretin Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Transthyretin Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 62. Europe Transthyretin Sales by Type (2023-2028) & (K Pcs)
Table 63. Europe Transthyretin Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Transthyretin Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 66. Europe Transthyretin Sales by Application (2023-2028) & (K Pcs)
Table 67. Europe Transthyretin Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Transthyretin Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Transthyretin Sales by Country (2017-2022) & (K Pcs)
Table 70. Europe Transthyretin Sales by Country (2023-2028) & (K Pcs)
Table 71. Europe Transthyretin Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Transthyretin Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 74. Asia Pacific Transthyretin Sales by Type (2023-2028) & (K Pcs)
Table 75. Asia Pacific Transthyretin Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Transthyretin Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 78. Asia Pacific Transthyretin Sales by Application (2023-2028) & (K Pcs)
Table 79. Asia Pacific Transthyretin Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Transthyretin Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Transthyretin Sales by Region (2017-2022) & (K Pcs)
Table 82. Asia Pacific Transthyretin Sales by Region (2023-2028) & (K Pcs)
Table 83. Asia Pacific Transthyretin Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Transthyretin Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 86. Latin America Transthyretin Sales by Type (2023-2028) & (K Pcs)
Table 87. Latin America Transthyretin Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Transthyretin Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 90. Latin America Transthyretin Sales by Application (2023-2028) & (K Pcs)
Table 91. Latin America Transthyretin Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Transthyretin Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Transthyretin Sales by Country (2017-2022) & (K Pcs)
Table 94. Latin America Transthyretin Sales by Country (2023-2028) & (K Pcs)
Table 95. Latin America Transthyretin Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Transthyretin Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Transthyretin Sales by Type (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Transthyretin Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Transthyretin Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Transthyretin Sales by Application (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Transthyretin Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Transthyretin Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Transthyretin Sales by Country (2017-2022) & (K Pcs)
Table 106. Middle East and Africa Transthyretin Sales by Country (2023-2028) & (K Pcs)
Table 107. Middle East and Africa Transthyretin Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Transthyretin Revenue by Country (2023-2028) & (US$ Million)
Table 109. Alnylam Pharmaceuticals Inc Corporation Information
Table 110. Alnylam Pharmaceuticals Inc Description and Major Businesses
Table 111. Alnylam Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Alnylam Pharmaceuticals Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Alnylam Pharmaceuticals Inc Recent Developments
Table 114. Arcturus Therapeutics Inc Corporation Information
Table 115. Arcturus Therapeutics Inc Description and Major Businesses
Table 116. Arcturus Therapeutics Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Arcturus Therapeutics Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Arcturus Therapeutics Inc Recent Developments
Table 119. Ionis Pharmaceuticals Inc Corporation Information
Table 120. Ionis Pharmaceuticals Inc Description and Major Businesses
Table 121. Ionis Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Ionis Pharmaceuticals Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Ionis Pharmaceuticals Inc Recent Developments
Table 124. Neurimmune Holding AG Corporation Information
Table 125. Neurimmune Holding AG Description and Major Businesses
Table 126. Neurimmune Holding AG Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Neurimmune Holding AG Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Neurimmune Holding AG Recent Developments
Table 129. Pfizer Inc Corporation Information
Table 130. Pfizer Inc Description and Major Businesses
Table 131. Pfizer Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. Pfizer Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Pfizer Inc Recent Developments
Table 134. Prothena Corp Plc Corporation Information
Table 135. Prothena Corp Plc Description and Major Businesses
Table 136. Prothena Corp Plc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. Prothena Corp Plc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Prothena Corp Plc Recent Developments
Table 139. Regeneron Pharmaceuticals Inc Corporation Information
Table 140. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 141. Regeneron Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 142. Regeneron Pharmaceuticals Inc Transthyretin Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Regeneron Pharmaceuticals Inc Recent Developments
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Transthyretin Distributors List
Table 147. Transthyretin Customers List
Table 148. Transthyretin Market Trends
Table 149. Transthyretin Market Drivers
Table 150. Transthyretin Market Challenges
Table 151. Transthyretin Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Transthyretin Product Picture
Figure 3. Global Transthyretin Market Share by Type in 2021 & 2028
Figure 3. AG-10 Product Picture
Figure 4. ALN-TTRsc02 Product Picture
Figure 5. CRX-1008 Product Picture
Figure 6. EDE-1307 Product Picture
Figure 7. Inotersen Sodium Product Picture
Figure 8. Others Product Picture
Figure 9. Global Transthyretin Market Share by Application in 2021 & 2028
Figure 10. Familial Amyloid Neuropathies
Figure 11. Alzheimer's Disease
Figure 12. Cardomyopathy
Figure 13. Neuropathy
Figure 14. Others
Figure 15. Transthyretin Report Years Considered
Figure 16. Global Transthyretin Sales 2017-2028 (K Pcs)
Figure 17. Global Transthyretin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Transthyretin Revenue 2017-2028 (US$ Million)
Figure 19. Global Transthyretin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Transthyretin Sales Market Share by Region (2017-2022)
Figure 21. Global Transthyretin Sales Market Share by Region (2023-2028)
Figure 22. North America Transthyretin Sales YoY (2017-2028) & (K Pcs)
Figure 23. North America Transthyretin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Transthyretin Sales YoY (2017-2028) & (K Pcs)
Figure 25. Europe Transthyretin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Transthyretin Sales YoY (2017-2028) & (K Pcs)
Figure 27. Asia-Pacific Transthyretin Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Transthyretin Sales YoY (2017-2028) & (K Pcs)
Figure 29. Latin America Transthyretin Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Transthyretin Sales YoY (2017-2028) & (K Pcs)
Figure 31. Middle East & Africa Transthyretin Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Transthyretin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Transthyretin in the World: Market Share by Transthyretin Revenue in 2021
Figure 34. Global Transthyretin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Transthyretin Sales Market Share by Type (2017-2028)
Figure 36. Global Transthyretin Revenue Market Share by Type (2017-2028)
Figure 37. Global Transthyretin Sales Market Share by Application (2017-2028)
Figure 38. Global Transthyretin Revenue Market Share by Application (2017-2028)
Figure 39. North America Transthyretin Sales Market Share by Type (2017-2028)
Figure 40. North America Transthyretin Revenue Market Share by Type (2017-2028)
Figure 41. North America Transthyretin Sales Market Share by Application (2017-2028)
Figure 42. North America Transthyretin Revenue Market Share by Application (2017-2028)
Figure 43. North America Transthyretin Sales Share by Country (2017-2028)
Figure 44. North America Transthyretin Revenue Share by Country (2017-2028)
Figure 45. U.S. Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Transthyretin Sales Market Share by Type (2017-2028)
Figure 48. Europe Transthyretin Revenue Market Share by Type (2017-2028)
Figure 49. Europe Transthyretin Sales Market Share by Application (2017-2028)
Figure 50. Europe Transthyretin Revenue Market Share by Application (2017-2028)
Figure 51. Europe Transthyretin Sales Share by Country (2017-2028)
Figure 52. Europe Transthyretin Revenue Share by Country (2017-2028)
Figure 53. Germany Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 54. France Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Transthyretin Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Transthyretin Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Transthyretin Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Transthyretin Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Transthyretin Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Transthyretin Revenue Share by Region (2017-2028)
Figure 64. China Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 67. India Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Transthyretin Sales Market Share by Type (2017-2028)
Figure 75. Latin America Transthyretin Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Transthyretin Sales Market Share by Application (2017-2028)
Figure 77. Latin America Transthyretin Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Transthyretin Sales Share by Country (2017-2028)
Figure 79. Latin America Transthyretin Revenue Share by Country (2017-2028)
Figure 80. Mexico Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Transthyretin Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Transthyretin Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Transthyretin Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Transthyretin Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Transthyretin Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Transthyretin Revenue Share by Country (2017-2028)
Figure 89. Turkey Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Transthyretin Revenue (2017-2028) & (US$ Million)
Figure 92. Transthyretin Value Chain
Figure 93. Transthyretin Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alnylam Pharmaceuticals Inc Arcturus Therapeutics Inc Ionis Pharmaceuticals Inc Neurimmune Holding AG Pfizer Inc Prothena Corp Plc Regeneron Pharmaceuticals Inc